HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor.

Abstract
Monocyte chemotactic protein-3 (MCP-3) is a C-C chemokine that interacts with the CCR1, CCR2, and CCR3 receptors and has a spectrum of action encompassing T cells, NK cells, eosinophils, and dendritic cells (DC), in addition to mononuclear phagocytes. This broad spectrum of action prompted the present study aimed at assessing the antitumor activity of MCP-3 in a gene transfer approach and at providing information as to the actual in vivo leukocyte recruiting capacity of MCP-3. P815 mastocytoma cells transfected with the gene coding MCP-3 (P815/MCP-3) grew in syngeneic hosts and underwent rejection. Rejection was associated with profound alterations of leukocyte infiltration and resistance to subsequent challenge with P815 cells. Tumor-associated macrophages, already present in copious numbers, T cells, eosinophils, and neutrophils, increased in tumor tissues after gene transfer. DC, identified as DEC205+, high MHC class II+, CD11c+ cells, did not increase substantially in the tumor mass. However, in peritumoral tissues, DC accumulated in perivascular areas. P815/MCP-3-transfected tumor cells grew normally in nude mice. Increased accumulation of macrophages and polymorphonuclear neutrophils was evident also in nude mice. mAb against CD4, CD8, and IFN-gamma, but not against IL-4, inhibited rejection of MCP-3-producing cells. An anti-polymorphonuclear mAb caused only a retardation of MCP-3-elicited tumor rejection. Thus, MCP-3 gene transfer elicits tumor rejection by activating type I T cell-dependent immunity. It is tempting to speculate that altered trafficking of APCs, which express receptors and respond to MCP-3, together with recruitment of activated T cells, underlies activation of specific immunity by MCP-3-transfected cells.
AuthorsF Fioretti, D Fradelizi, A Stoppacciaro, S Ramponi, L Ruco, A Minty, S Sozzani, C Garlanda, A Vecchi, A Mantovani
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 161 Issue 1 Pg. 342-6 (Jul 01 1998) ISSN: 0022-1767 [Print] United States
PMID9647242 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ccl7 protein, mouse
  • Chemokine CCL7
  • Cytokines
  • Monocyte Chemoattractant Proteins
Topics
  • Animals
  • Cell Movement (genetics, immunology)
  • Chemokine CCL7
  • Cytokines
  • Dendritic Cells (immunology, pathology)
  • Gene Transfer Techniques
  • Graft Rejection (genetics)
  • Immunity, Innate
  • Leukocytes (immunology)
  • Male
  • Mast-Cell Sarcoma (genetics, immunology, pathology)
  • Mice
  • Mice, Inbred DBA
  • Mice, Nude
  • Monocyte Chemoattractant Proteins (genetics)
  • Neoplasm Transplantation
  • Neutrophils (immunology, pathology)
  • Transfection (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: